| 000 | 01631 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515064711.0 | ||
| 264 | 0 | _c20070918 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2006.066787 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimsek, Ismail | |
| 245 | 0 | 0 |
_aOptic neuritis occurring with anti-tumour necrosis factor alpha therapy. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cSep 2007 |
||
| 300 |
_a1255-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOptic Neuritis _xchemically induced |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aErdem, Hakan | |
| 700 | 1 | _aPay, Salih | |
| 700 | 1 | _aSobaci, Gungor | |
| 700 | 1 | _aDinc, Ayhan | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 66 _gno. 9 _gp. 1255-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2006.066787 _zAvailable from publisher's website |
| 999 |
_c17005800 _d17005800 |
||